The estimated number of youth with office visits with a diagnosis of bipolar disorder substantially increased between 1994 and 2003, while adult visits with a bipolar disorder diagnoses appeared to almost double, according to a report in the September issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
The European Association of Urology (EAU) will soon launch an online prostate cancer risk assessment tool that will aid urologists, family physicians and men aged 55 years and older to properly evaluate the chance of developing prostate cancer.
Shame and undetected symptoms are among the key reasons why middle-aged European males neglect to seek medical help when experiencing prostate ailments.
People with type 2 diabetes are more prone to have some heart disease, high blood pressure or stroke. Using a combination of diuretics and ACE inhibitors to manage blood pressure in these people with type 2 diabetes can help protect against heart disease, revealed by researchers in a recent worldwide study known as ADVANCE.
GlaxoSmithKline announced that the European Medicines Agency (EMEA) has authorised a new indication for its once-daily anticoagulant ARIXTRA? 2.5 mg (fondaparinux sodium) for the treatment of specific acute coronary syndromes (ACS).
Cardiac patients would soon be able to grow their own heart valves and have them transplanted within weeks of seeing a doctor, revealed by British researchers.
An investigational, phase II study published in the scientific journal Nature Medicine demonstrates that for the first time in humans a drug that acts on certain proteins in the brain called mGlu2/3 has antipsychotic activity. The study was sponsored by Eli Lilly and Company (NYSE: LLY).
Among a growing number of Americans seeking general health information and information about cancer, the Internet remains a frequent first source, even though the public?s trust in online material about health has declined, reports a government study.
We often think that high-tech, surgical methods are the best approach when it comes to medical care. But for children born with clubfoot, there is growing, worldwide interest in a low-tech, non-surgical method of treatment that is more effective, less expensive and easier to provide than surgery.
The U.S. Food and Drug Administration today approved Somatuline Depot (lanreotide acetate injection) for the treatment of acromegaly, a rare and potentially life threatening disease in adults caused by abnormal secretion of growth hormone (GH), commonly from a benign tumor located in the pituitary gland located in the brain.